Recalls / Class II

Class IID-1260-2015

Product

Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-953-01) and B) 500 Count Bottles (NDC: 64679-953-05), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.

Affected lot / code info

A) Lot #: DM11003, Expiry: 4/30/2015; Lot #: DM11094, Expiry: 4/30/2015; Lot #: DM11689, Expiry: 6/30/2015; Lot #: DM11873, Expiry: 6/30/2015; Lot #: DM11874, Expiry: 6/30/2015; Lot #: DM12402, Expiry: 8/31/2015; Lot #: DM12412, Expiry: 8/31/2015; Lot #: DM13440, Expiry: 11/30/2015; Lot #: DN10689, Expiry: 1/31/2016; Lot #: DN10693, Expiry: 1/31/2016. B) Lot #: DM11095, Expiry: 4/30/2015; Lot #: DM11688, Expiry: 6/30/2015; Lot #: DM11860, Expiry: 6/30/2015; Lot #: DM12413, Expiry: 8/31/2015; Lot #: DN10692, Expiry: 1/31/2016.

Why it was recalled

CGMP Deviations: Firm did not adequately investigate customer complaints.

Recalling firm

Firm

Wockhardt Usa Inc.

Notification channel

Letter

Type

Voluntary: Firm initiated

Address

20 Waterview Blvd Ste 3, N/A, Parsippany, New Jersey 07054-1271

Distribution

Quantity

A) 63,203 Bottles and B) 6,094 Bottles.

Distribution pattern

U.S. Nationwide including Puerto Rico.

Timeline

Recall initiated

2015-04-22

FDA classified

2015-07-17

Posted by FDA

2015-07-29

Terminated

2018-05-09

Status

Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1260-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.